Guadalupe G. San Miguel

Guadalupe G. San Miguel

Auto-generated profile, based on publicly available information

Guadalupe G. San Miguel

Utah State University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Cognitive Behaviour Therapy
Verified
Journal Article
Open access
KKKorena S Klimczak
Korena S Klimczak
GMGuadalupe G. San Miguel
Guadalupe G. San Miguel
MMMiriam Mukasa
Miriam Mukasa
MTMichael P. Twohig
Michael P. Twohig
MLMichael Edward Levin
Michael Edward Levin
Online Acceptance and Commitment Therapy (ACT) interventions use websites and smartphone apps to deliver ACT exercises and skills. The present meta-analysis provides a comprehensive review of online ACT self-help interventions, characterizing the programs that have been studied (e.g. platform, length, content) and analyzing their efficacy. A transdiagnostic approach was taken, including studies that addressed a range of targeted problems and populations. Multi-level meta-analyses were used to nest multiple measures of a single construct within their respective studies. A total of 53 randomized controlled trials were included (n = 10,730). Online ACT produced significantly greater outcomes than waitlist controls at post-treatment for anxiety, depression, quality of life, psychological flexibility, and all assessed outcomes (i.e. omnibus effect), which were generally maintained at follow-up. However, only psychological flexibility and all assessed outcomes at post-treatment were found to be significantly greater for online ACT when compared to active controls, with no significant follow-up effects. Overall, these results further clarify that ACT can be effectively delivered in an online format to target a wide range of mental health concerns, although it is less clear if and when online ACT is more efficacious than other online interventions.

1 November 2024 in Training and Education in Professional Psychology
Verified
Journal Article
Closed access
JVJosé Manuel González Vera
José Manuel González Vera
MRMelanie M. Domenech Rodríguez
Melanie M. Domenech Rodríguez
CFCynthia M. Navarro Flores
Cynthia M. Navarro Flores
AVAlejandro L. Vázquez
Alejandro L. Vázquez
GMGuadalupe G. San Miguel
Guadalupe G. San Miguel
JEJuan Estrada
Juan Estrada

10 April 2026 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
JPJulie M. Petersen
Julie M. Petersen
EBEmily M. Bowers
Emily M. Bowers
MWMercedes G. Woolley
Mercedes G. Woolley
GMGuadalupe G. San Miguel
Guadalupe G. San Miguel
KMKaren Muñoz
Karen Muñoz
MTMichael P. Twohig
Michael P. Twohig
Misophonia is characterized by intense emotional and physiological responses to specific auditory triggers, typically repetitive, human-generated sounds. Treatment research in misophonia is nascent, with several studies showing promising outcomes across a range of treatments. While these findings suggest that misophonia symptoms are responsive to psychological interventions, more research is needed to identify which treatments are most effective, and for whom. This study examined baseline prognostic factors of treatment outcome from a randomized controlled trial for adults with misophonia, comparing acceptance and commitment therapy to progressive relaxation training for misophonia. Using multilevel modeling, the following baseline variables were tested as prognostic factors of clinician- and self-reported misophonia symptoms over time: age, age of misophonia onset, number of comorbid psychological diagnoses, psychological flexibility, and baseline misophonia severity. While exploratory, the findings suggest that older age, earlier age of onset and greater comorbidity, psychological inflexibility, and baseline symptom severity have small-to-moderate clinical and statistical effects on the longitudinal maintenance of treatment gains. Together, these findings highlight the complexity of treating misophonia and identifying potential treatment responders early on.